Elanco Animal Health (ELAN) Capital Expenditures Growth (3y) (2020 - 2026)
Elanco Animal Health (ELAN) Capital Expenditures Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.24 Bn | 87.37 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn | 6.52% |
| 3 | Zoetis | 32.51 Bn | 30.56 Bn | 1.62 Bn | 232.22% |
| 4 | Takeda Pharmaceutical | 27.58 Bn | 23.52 Bn | 4.39 Bn | 1.64% |
| 5 | United Therapeutics | 23.18 Bn | 21.02 Bn | 648.10 Mn | 75.58% |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | -5.84% |
| 8 | Neurocrine Biosciences | 17.94 Bn | 16.63 Bn | 800.70 Mn | 32.64% |
| 9 | Elanco Animal Health | 12.73 Bn | 12.30 Bn | 785.00 Mn | 28.56% |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn | 279.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.56% |
| Dec 31, 2025 | -6.97% |
| Sep 30, 2025 | 36.72% |
| Jun 30, 2025 | 3.78% |
| Mar 31, 2025 | 110.19% |
| Dec 31, 2024 | -31.77% |
| Sep 30, 2024 | 253.03% |
| Jun 30, 2024 | 97.18% |
| Mar 31, 2024 | 10.06% |
| Dec 31, 2023 | 13.56% |
| Sep 30, 2023 | -27.89% |
| Jun 30, 2023 | -3.68% |
| Mar 31, 2023 | 22.67% |
| Dec 31, 2022 | -9.48% |
| Sep 30, 2022 | 62.71% |
| Jun 30, 2022 | 28.92% |
| Mar 31, 2022 | -37.00% |
| Dec 31, 2021 | 34.97% |
| Sep 30, 2021 | -27.16% |
| Jun 30, 2021 | -31.08% |